Literature DB >> 14566565

Relationship between double product break point, lactate threshold, and ventilatory threshold in cardiac patients.

Kazuto Omiya1, Haruki Itoh, Naomi Harada, Tomoko Maeda, Akihiko Tajima, Keiko Oikawa, Akira Koike, Tadanori Aizawa, Long-Tai Fu, Naohiko Osada.   

Abstract

A double product break point (DPBP) occurs simultaneously with both ventilatory threshold (VT) and lactate threshold (LT) in normal subjects. We sought to determine whether a DPBP also occurs in cardiac patients and to investigate correlations between DPBP, VT and LT (study 1). We also evaluated a non-invasive DPBP measurement system that determined blood pressure automatically by the cuff method (study 2). Study 1 comprised 15 patients [8 men and 7 women, mean (SD) age 47.7 (11.1) years] who performed cardiopulmonary exercise tests on a cycle ergometer. The double product was defined as the product of heart rate and direct systolic blood pressure. Arterial blood samples were obtained for measurement of lactate, pyruvate, pH, and norepinephrine levels. VT was determined by gas analysis, and LT was determined as the lactate/pyruvate ratio. DPBPs were detected in all 15 patients. Double product slopes above the DPBP were significantly greater than those below the DPBP (286.2 vs 98.5/W, P<0.001). The lactate/pyruvate ratio increased, arterial pH decreased, and plasma norepinephrine concentration increased above the DPBP. DPBP had strong positive correlations with VT ( r=0.93) and LT ( r=0.95). Study 2 comprised 65 cardiac patients. The DPBP was detected in 89.2% of patients and correlated closely with VT. We conclude that DPBP occurs near VT and LT in cardiac patients during incremental exercise, that the noninvasive DPBP measurement method is comparable to the invasive method, and that DPBP may be as useful an index of exercise intensity in patients with cardiac disease as VT or LT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566565     DOI: 10.1007/s00421-003-0959-3

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  14 in total

1.  Identification of the anaerobic threshold using double product in patients with coronary artery disease.

Authors:  P H Brubaker; A Kiyonaga; B A Matrazzo; W E Pollock; M Shindo; H S Miller; H Tanaka
Journal:  Am J Cardiol       Date:  1997-02-01       Impact factor: 2.778

2.  Double product response is accelerated above the blood lactate threshold.

Authors:  H Tanaka; A Kiyonaga; Y Terao; K Ide; M Yamauchi; M Tanaka; M Shindo
Journal:  Med Sci Sports Exerc       Date:  1997-04       Impact factor: 5.411

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Association between the anaerobic threshold and the break-point in the double product/work rate relationship.

Authors:  M Riley; K Maehara; J Pórszász; M P Engelen; T J Bartstow; H Tanaka; K Wasserman
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1997

5.  Effect of training program based on anaerobic threshold in the early phase after acute myocardial infarction.

Authors:  M Doi; H Itoh; A Niwa; K Taniguchi; M Hiroe; F Marumo
Journal:  Cardiologia       Date:  1997-10

6.  Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization.

Authors:  W S Colucci; J P Ribeiro; M B Rocco; R J Quigg; M A Creager; J D Marsh; D F Gauthier; L H Hartley
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

7.  Prediction of exercise tolerance in the chronic phase of myocardial infarction by using ventilatory gas analysis.

Authors:  K Tanabe; T Iwasaki; N Osada; K Omiya; M Yamamoto; H Itoh; M Murayama; J Sugai; S Yamada; H Yamasaki
Journal:  Jpn Circ J       Date:  1993-03

8.  Management and evaluation of non-supervised home exercise program in a convalescent phase of acute myocardial infarction.

Authors:  K Ueshima; M Saito; A Shimohara; S Uchimoto; M Kawaguchi; K Fukami; T Sumiyoshi; K Haze; K Hiramori
Journal:  Jpn Circ J       Date:  1990-11

9.  Influence of aerobic exercise training on brain natriuretic peptide secretion in patients in the chronic phase of myocardial infarction.

Authors:  A Yamamoto; K Tanabe; Y Yokoyama; H Itoh; M Murayama
Journal:  Jpn Circ J       Date:  1998-09

10.  Detecting abnormalities in left ventricular function during exercise by respiratory measurement.

Authors:  A Koike; H Itoh; K Taniguchi; M Hiroe
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

View more
  5 in total

1.  The influence of aerobic exercise training on the double product break point in low-to-moderate risk adults.

Authors:  Trent A Hargens; Diane C Griffin; Leonard A Kaminsky; Mitchell H Whaley
Journal:  Eur J Appl Physiol       Date:  2010-09-28       Impact factor: 3.078

2.  The influence of weight loss on anaerobic threshold in obese women.

Authors:  Agnieszka Zak-Golab; Barbara Zahorska-Markiewicz; Józef Langfort; Piotr Kocelak; Michal Holecki; Katarzyna Mizia-Stec; Magdalena Olszanecka-Glinianowicz; Jerzy Chudek
Journal:  J Sports Sci Med       Date:  2010-12-01       Impact factor: 2.988

3.  Anaerobic Threshold and Salivary α-amylase during Incremental Exercise.

Authors:  Kazunori Akizuki; Syouichirou Yazaki; Yuki Echizenya; Yukari Ohashi
Journal:  J Phys Ther Sci       Date:  2014-07-30

4.  Double product break point estimates ventilatory threshold in individuals with type 2 diabetes.

Authors:  Caio Victor de Sousa; Marcelo Magalhães Sales; Samuel da Silva Aguiar; Daniel Alexandre Boullosa; Thiago Dos Santos Rosa; Vilmar Baldissera; Herbert Gustavo Simões
Journal:  J Phys Ther Sci       Date:  2016-06-28

5.  Detection of ventilatory thresholds using near-infrared spectroscopy with a polynomial regression model.

Authors:  Chih-Wei Lin; Chun-Feng Huang; Jong-Shyan Wang; Li-Lan Fu; Tso-Yen Mao
Journal:  Saudi J Biol Sci       Date:  2020-03-12       Impact factor: 4.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.